1. Increasing the reach: optimizing screening for atrial fibrillation-the STROKESTOP III study.
- Author
-
Khan M, Ingre M, Carlstedt F, Eriksson A, Skröder S, Star Tenn J, Rosenqvist M, and Svennberg E
- Subjects
- Humans, Aged, Prospective Studies, Electrocardiography, Male, Sweden epidemiology, Female, Risk Factors, Early Diagnosis, Atrial Fibrillation diagnosis, Atrial Fibrillation drug therapy, Mass Screening methods
- Abstract
Aims: Atrial fibrillation (AF) is the most common type of cardiac arrythmia and is an important risk factor for ischaemic stroke. Many cases of AF remain undiagnosed due to its paroxysmal, intermittent, and often asymptomatic nature. Early detection of AF through screening and initiation of treatment with oral anticoagulants can prevent stroke, increase life expectancy, and decrease the cost of healthcare for the society. However, participation has been low in previous AF screening studies employing population screening. The aim of this study is to determine whether opportunistic screening is a superior method to increase participation in comparison to population screening. We hypothesize that opportunistic screening will significantly increase participation., Methods and Results: In our study, STROKESTOP III, a randomized prospective cohort study, we compare two different methods of AF screening in high-risk individuals: population screening vs. opportunistic screening. Sixteen different primary clinics in Värmland, Sweden, serving 75-76-year-old individuals (n = 2954), will be randomized to either population screening or opportunistic screening. The individuals will be instructed to record electrocardiogram (ECG) for 30 s, 3 times daily for 2 weeks, using a handheld one-lead ECG device. Patients with detected AF will be referred to their primary healthcare physician and offered treatment. The main objective of the study is to determine the rate of participation in opportunistic screening in comparison to population screening., Conclusions: The STROKESTOP III study will provide valuable information on which screening method to use for improved participation in atrial fibrillation screening., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2024
- Full Text
- View/download PDF